News & Press
April 17, 2020
DCAT Podcast Sponsored by CordenPharma> Facilitating Sourcing in the Wake of COVID-19 patients.
What measures are being taken by European Union authorities to mitigate potential shortages stemming from supply-chain and manufacturing disruptions? In this podcast we feature an article that outlines the guidance issued by EU authorities to provide flexibility in sourcing for crucial medicines for the treatment of COVID-19. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
COVID-19’s Impact on Global Pharma Supply Chains
Indian Government Looks to Increase API Manufacturing
Drug Supply Chains and US-Based Manufacturing
Blockbuster Watch for 2020: New Market Entrants
Orphan Drugs: Bearing Revenue Gains or Not?
Emerging Biopharma Companies: Tracking Their Contribution to Innovation